These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12735878)

  • 21. Cumulative live birth rates according to the number of oocytes retrieved after the first ovarian stimulation for in vitro fertilization/intracytoplasmic sperm injection: a multicenter multinational analysis including ∼15,000 women.
    Polyzos NP; Drakopoulos P; Parra J; Pellicer A; Santos-Ribeiro S; Tournaye H; Bosch E; Garcia-Velasco J
    Fertil Steril; 2018 Sep; 110(4):661-670.e1. PubMed ID: 30196963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modified natural cycle in in vitro fertilization.
    Ho JR; Paulson RJ
    Fertil Steril; 2017 Oct; 108(4):572-576. PubMed ID: 28965551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization.
    Kuang Y; Chen Q; Fu Y; Wang Y; Hong Q; Lyu Q; Ai A; Shoham Z
    Fertil Steril; 2015 Jul; 104(1):62-70.e3. PubMed ID: 25956370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can ovarian double-stimulation in the same menstrual cycle improve IVF outcomes?
    Cardoso MCA; Evangelista A; Sartório C; Vaz G; Werneck CLV; Guimarães FM; Sá PG; Erthal MC
    JBRA Assist Reprod; 2017 Sep; 21(3):217-221. PubMed ID: 28837031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization.
    Jiang S; Kuang Y
    Clin Endocrinol (Oxf); 2018 Jan; 88(1):77-87. PubMed ID: 28960429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thirty years of IVF: the legacy of Patrick Steptoe and Robert Edwards.
    Brinsden PR; Brinsden PR
    Hum Fertil (Camb); 2009; 12(3):137-43. PubMed ID: 19925325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Small doses of LH activity are needed early in ovarian stimulation for better quality oocytes in IVF-ET.
    Drakakis P; Loutradis D; Kallianidis K; Liapi A; Milingos S; Makrigiannakis A; Dionyssiou-Asteriou A; Michalas S
    Eur J Obstet Gynecol Reprod Biol; 2005 Jul; 121(1):77-80. PubMed ID: 15989987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased risk of preterm birth and low birthweight with very high number of oocytes following IVF: an analysis of 65 868 singleton live birth outcomes.
    Sunkara SK; La Marca A; Seed PT; Khalaf Y
    Hum Reprod; 2015 Jun; 30(6):1473-80. PubMed ID: 25883033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is the modified natural in vitro fertilization cycle justified in patients with "genuine" poor response to controlled ovarian hyperstimulation?
    Kedem A; Tsur A; Haas J; Yerushalmi GM; Hourvitz A; Machtinger R; Orvieto R
    Fertil Steril; 2014 Jun; 101(6):1624-8. PubMed ID: 24680364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.
    Vuong TN; Phung HT; Ho MT
    Hum Reprod; 2015 May; 30(5):1188-95. PubMed ID: 25740882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [INFLUENCE OF STIMULATION PROTOCOL ON MATURITY AND MORPHOLOGICAL FEATURES OF OOCYTES IN PATIENTS WITH LOW OVARIAN RESERVE: STUDY OF 72 IVF/ICSI TREATMENT CYCLES].
    Ingilizova ; Kovachev E; Ivanov D; Kostov I; Ivanov S
    Akush Ginekol (Sofiia); 2016; 55(3):10-3. PubMed ID: 27514137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The myths surrounding mild stimulation in vitro fertilization (IVF).
    Orvieto R; Vanni VS; Gleicher N
    Reprod Biol Endocrinol; 2017 Jun; 15(1):48. PubMed ID: 28645286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant LH supplementation to a standard GnRH antagonist protocol in women of 35 years or older undergoing IVF/ICSI: a randomized controlled multicentre study.
    König TE; van der Houwen LE; Overbeek A; Hendriks ML; Beutler-Beemsterboer SN; Kuchenbecker WK; Renckens CN; Bernardus RE; Schats R; Homburg R; Hompes PG; Lambalk CB
    Hum Reprod; 2013 Oct; 28(10):2804-12. PubMed ID: 23838159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mild stimulation in in vitro fertilization.
    Macklon NS; Fauser BC
    Ann N Y Acad Sci; 2003 Nov; 997():105-11. PubMed ID: 14644815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Medroxyprogesteron acetate use to block LH surge in oocyte donor stimulation].
    Crha I; Ventruba P; Filipinská E; Dziakova M; Žáková J; Ješeta M; Lousová E; Papíková Z
    Ceska Gynekol; 2018; 83(1):11-16. PubMed ID: 29510633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mild stimulation for in vitro fertilization.
    Nargund G; Datta AK; Fauser BCJM
    Fertil Steril; 2017 Oct; 108(4):558-567. PubMed ID: 28965549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Correlation between serum inhibin B level after treatment with gonadotropin releasing hormone agonist and outcome of in vitro fertilization-embryo transfer].
    Lin WQ; Yang HY; Lin JJ; Chen X; Ye BL
    Zhonghua Fu Chan Ke Za Zhi; 2009 Apr; 44(4):260-2. PubMed ID: 19570462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.
    Hohmann FP; Macklon NS; Fauser BC
    J Clin Endocrinol Metab; 2003 Jan; 88(1):166-73. PubMed ID: 12519847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emergency IVF for embryo freezing to preserve female fertility: a French multicentre cohort study.
    Courbiere B; Decanter C; Bringer-Deutsch S; Rives N; Mirallié S; Pech JC; De Ziegler D; Carré-Pigeon F; May-Panloup P; Sifer C; Amice V; Schweitzer T; Porcu-Buisson G; Poirot C;
    Hum Reprod; 2013 Sep; 28(9):2381-8. PubMed ID: 23832792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.